Production of Lentiviral Vectors

Transfection of Expression Plasmids
Envelope Proteins
Virion Packaging
Budding of the Virion
Purification of the Vector

Lentiviral vector production is complex. Non viral expression plasmids are produced which encode the structural components of the virus and the packaging elements required to package the viral single stranded RNA into the final vector. The entire production process takes place inside human cells grown in culture.


Transfection of Expression Plasmids^Top

The plasmids encoding the viral coat proteins, the virion components and the genome plasmid are transfected into human cell culture.

They are imported into the cell nucleus and start expressing the genes they encode.

The experience gained during our non-viral vector development programme means we are able to carefully optimise the plasmid molecules so they


Envelope Proteins^Top

The envelope proteins direct the tissue specificity of the lentiviral vector.

In the case of our work we express modified versions of the Sendai Virus H & FN proteins to try and re-target the lentivirus.

However, they are not directly packaged into the vector but are exported to the cell membrane of the production cell.


Virion Packaging^Top

The virion proteins and produced and remain within the cell.

The LV genome is single stranded RNA which is produced from the genome plasmid. The ssRNA genome is packaged into the virion.


Budding of the Virion^Top

The viral virions fuse with the cell membrane of the production cell and bud off into the cell culture medium.

This process ensures that the final vectors and surrounded by a lipid bilayer which contains the envelope proteins.

 

Vector Purification^Top

Various filtration and purification methods are then used to process the cell culture media. This produces a final vector fraction free of contaminants, other cell products or the plasmid molecules.

Site map

 

Home
News
Contact Details
Follow us on Facebook
Events & Fundraising
Careers
Site Feedback
Site Search
The CF Trust

 

Information for Patients on Our Clinical Trial
Latest Clinical Trial News
Contact Details

 

Consortium Members' Internal Website
About Us
How the Consortium Works
Profiles of the Strategy Group
Scientific Advisory Committee
Milestones
Comminuty Review
Oxford University Gene Medicine
Centre for Molecular Medicine, Edinburgh
The Roslin Institute
Dep of Gene Therapy, Imperial

 

Our Research
Optimisation of pDNA
Aerosol Delivery
Viral Vectors Development
Assay Development
Core Facilities
Consortium Patents

 

Clinical Programme
GL67A/pGM169
Clinical Team
Tracking Study
The Run-in Study
Single Dose Clinical Trial
Multi Dose Clinical Trial

 

Cystic Fibrosis
What is CF?
History of CF
Discovery of the CFTR Gene
What Causes CF?
CFTR Protein Structure
Cystic Fibrosis Links
Gene Therapy
Introduction to CF Gene Therapy
Why use Gene Therapy for CF?
Other CF Gene Therapy Groups
Examples of Successful Gene Therapy
Gene Therapy Links

 

Publications
Publications in Journals
Conference Posters & Presentations
Book Chapters
Lectures

 

Medical Futures Innovation Award 2011
Introductory Video
What is a Lentivirus
Production of Lentiviruses
Progress to Date
DNAVec
Photo Gallery